Publications

Export 130 results:
Sort by: Author [ Title (Asc)] Type Year
Filters: First Letter Of Title is I  [Clear All Filters]
A B C D E F G H [I] J K L M N O P Q R S T U V W X Y Z   [Show ALL]
I
Manning JR, Bailey MA, Soares DC, Dunbar DR, Mullins JJ. In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence. Physiological genomics. 2010;42:319-30. Abstract
Dunbar DR, Shibasaki Y, Dobbie L, Andersson B, Brookes AJ. In situ hybridisation mapping of genomic clones for five human respiratory chain complex I genes. Cytogenet Cell Genet. 1997;78(1):21-4. Abstract
Moran CM, Watson RJ, Fox KA, McDicken WN. In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz. Ultrasound in medicine & biology. 2002;28:785-91. Abstract
Sboros V, Moran CM, Anderson T, McDicken WN. An in vitro comparison of ultrasonic contrast agents in solutions with varying air levels. Ultrasound Med Biol. 2000;26(5):807-18. Abstract
Péault B, Khazaal I, Weissman IL. In vitro development of B cells and macrophages from early mouse fetal thymocytes. Eur J Immunol. 1994;24(3):781-4. Abstract
Sboros V, Moran CM, Pye SD, McDicken WN. An in vitro study of a microbubble contrast agent using a clinical ultrasound imaging system. Phys Med Biol. 2004;49(1):159-73. Abstract
Sboros V, Moran CM, Anderson T, Gatzoulis L, Criton A, Averkiou M, et al. An in vitro system for the study of ultrasound contrast agents using a commercial imaging system. Phys Med Biol. 2001;46(12):3301-21. Abstract
Bailey MA, Unwin RJ, Shirley DG. In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption. Clin Sci. 2001;101(2):195-8. Abstract
Clozel M, Breu V, Gray GA, Löffler BM. In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S377-9. Abstract
Heck MM, Hittelman WN, Earnshaw WC. In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. Cell cycle analysis. J Biol Chem. 1989;264(26):15161-4. Abstract
Cohen-Haguenauer O, Péault B, Bauche C, Daniel M-, Casal I, Levy V, et al. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc Natl Acad Sci USA. 2006;103(7):2340-5. Abstract
Shirley DG, Bailey MA, Unwin RJ. In vivo stimulation of apical P2 receptors in collecting ducts: evidence for inhibition of sodium reabsorption. Am J Physiol Renal Physiol. 2005;288(6):F1243-8. Abstract
López-Sendón J, Dabbous OH, López de Sá E, Stiles M, Gore JM, Brieger D, et al. In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. Rev Esp Cardiol. 2009;62(5):501-9. Abstract
Péault B. In-vitro models of stroma-dependent lymphopoiesis. Semin Immunol. 1995;7(3):169-75. Abstract
Husková Z, Vanourková Z, Erbanová M, Thumová M, Opocenský M, Mullins JJ, et al. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats. Journal of hypertension. 2010;28:495-509. Abstract
Morris Z, Whiteley WN, Longstreth WT, Weber F, Lee Y-, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016. Abstract
Jansen MA, van Echteld CJ, Ruigrok TJ. An increase in intracellular [Na+] during Ca2+ depletion is not related to Ca2+ paradox damage in rat hearts. Am J Physiol. 1998;274(3 Pt 2):H846-52. Abstract
Livingstone DE, McInnes KJ, Walker BR, Andrew R. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obesity research. 2005;13:1523-6. Abstract
Peters J, Münter K, Bader M, Hackenthal E, Mullins JJ, Ganten D. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium. The Journal of clinical investigation. 1993;91:742-7. Abstract
Michailidou Z, Turban S, Miller E, Zou X, Schrader J, Ratcliffe PJ, et al. Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11β-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J Biol Chem. 2012;287(6):4188-97. Abstract
Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63:306-11. Abstract
Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni GE, Ciampaglia W, et al. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J Endocrinol Invest. 2009;32(3):210-8. Abstract
Campbell DJ, Karam H, Bruneval P, Mullins JJ, Ménard J. Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease. Journal of hypertension. 2010;28:1429-37. Abstract
Jennings KA, Loder MK, Sheward JW, Pei Q, Deacon RM, Benson MA, et al. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006;26:8955-64. Abstract
Waters CM, Mackinnon AC, Cummings J, Tufail-Hanif U, Jodrell D, Haslett C, et al. Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition. Br J Cancer. 2003;88(11):1808-16. Abstract